Redeye: Saniona - Tesomet – A Potential Goldmine

Report this content

Redeye acknowledges another milestone for Saniona with the recently presented, positive results in rare eating disorders. We now look for sound funding solutions and the initiation of pivotal trials in the rare eating disorder space to complete the picture and drive a revaluation of the stock.

Read more in the research update by Anders Hedlund: https://bit.ly/35xgqaG 

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/

Prenumerera